These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 7606283)

  • 1. Cerebrovascular reactivity to acetazolamide in (senile) dementia of Alzheimer's type: relationship to disease severity.
    Stoppe G; Schütze R; Kögler A; Staedt J; Munz DL; Emrich D; Rüther E
    Dementia; 1995; 6(2):73-82. PubMed ID: 7606283
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 99mTc-HMPAO-SPECT in the diagnosis of senile dementia of Alzheimer's type--a study under clinical routine conditions.
    Stoppe G; Staedt J; Kögler A; Schütze R; Kunert HJ; Sandrock D; Munz DL; Emrich D; Rüther E
    J Neural Transm Gen Sect; 1995; 99(1-3):195-211. PubMed ID: 8579805
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Posterior cingulate hypoperfusion in Alzheimer's disease, senile dementia of Alzheimer type, and other dementias evaluated by three-dimensional stereotactic surface projections using Tc-99m HMPAO SPECT.
    Kaneko K; Kuwabara Y; Sasaki M; Ogomori K; Ichimiya A; Koga H; Nakagawa M; Hayashi K; Honda H
    Clin Nucl Med; 2004 Jun; 29(6):362-6. PubMed ID: 15166883
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cerebral blood flow and oxygen metabolism in senile dementia of Alzheimer's type and vascular dementia with deep white matter changes.
    Tohgi H; Yonezawa H; Takahashi S; Sato N; Kato E; Kudo M; Hatano K; Sasaki T
    Neuroradiology; 1998 Mar; 40(3):131-7. PubMed ID: 9561514
    [TBL] [Abstract][Full Text] [Related]  

  • 5. White matter magnetic resonance hyperintensities in dementia of the Alzheimer type: morphological and regional cerebral blood flow correlates.
    Waldemar G; Christiansen P; Larsson HB; Høgh P; Laursen H; Lassen NA; Paulson OB
    J Neurol Neurosurg Psychiatry; 1994 Dec; 57(12):1458-65. PubMed ID: 7798973
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of adenosine on cerebral blood flow as evaluated by single-photon emission computed tomography in normal subjects and in patients with occlusive carotid disease. A comparison with acetazolamide.
    Soricelli A; Postiglione A; Cuocolo A; De Chiara S; Ruocco A; Brunetti A; Salvatore M; Ell PJ
    Stroke; 1995 Sep; 26(9):1572-6. PubMed ID: 7660400
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vasoreactivity induced by acetazolamide in patients with vascular dementia versus Alzheimer's disease.
    Likitjaroen Y; Suwanwela NC; Phanthumchinda K
    J Neurol Sci; 2009 Aug; 283(1-2):32-5. PubMed ID: 19375084
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuropsychological, psychiatric, and cerebral perfusion correlates of leukoaraiosis in Alzheimer's disease.
    Starkstein SE; Sabe L; Vázquez S; Di Lorenzo G; Martínez A; Petracca G; Tesón A; Chemerinski E; Leiguarda R
    J Neurol Neurosurg Psychiatry; 1997 Jul; 63(1):66-73. PubMed ID: 9221970
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of positron emission tomography, cognition, and brain volume in Alzheimer's disease with and without severe abnormalities of white matter.
    DeCarli C; Grady CL; Clark CM; Katz DA; Brady DR; Murphy DG; Haxby JV; Salerno JA; Gillette JA; Gonzalez-Aviles A; Rapoport SI
    J Neurol Neurosurg Psychiatry; 1996 Feb; 60(2):158-67. PubMed ID: 8708645
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regional cerebral blood flow single-photon emission tomography with 99mTc-HMPAO and the acetazolamide test in the evaluation of vascular and Alzheimer's dementia.
    Pávics L; Grünwald F; Reichmann K; Horn R; Kitschenberg A; Hartmann A; Menzel C; Schomburg AG; Overbeck B; Csernay L; Biersack HJ
    Eur J Nucl Med; 1999 Mar; 26(3):239-45. PubMed ID: 10079314
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Studies of cerebral blood flow and metabolism in patients with senile dementia of the Alzheimer's type and diagnostic evaluation of the dementing illnesses by positron emission tomography].
    Sakamoto S
    Nihon Ika Daigaku Zasshi; 1990 Jun; 57(3):222-34. PubMed ID: 2376611
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of acetazolamide on regional cerebral blood flow in patients with Alzheimer's disease or stroke as measured by single-photon emission computed tomography.
    Bonte FJ; Devous MD; Reisch JS; Ajmani AK; Weiner MF; Hom J; Tintner R
    Invest Radiol; 1989 Feb; 24(2):99-103. PubMed ID: 2783927
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cerebral blood flow in white matter is correlated with systolic blood pressure and EEG in senile dementia of the Alzheimer type.
    Siennicki-Lantz A; Lilja B; Rosén I; Elmståhl S
    Dement Geriatr Cogn Disord; 1998; 9(1):29-38. PubMed ID: 9469263
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of acetazolamide reactivity in cerebral blood flow using spectral analysis and technetium-99m hexamethylpropylene amine oxime.
    Takasawa M; Murase K; Oku N; Yoshikawa T; Osaki Y; Imaizumi M; Matsuzawa H; Fujino K; Hashikawa K; Kitagawa K; Hori M; Matsumoto M
    J Cereb Blood Flow Metab; 2002 Aug; 22(8):1004-9. PubMed ID: 12172386
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Accurate prediction of histologically confirmed Alzheimer's disease and the differential diagnosis of dementia: the use of NINCDS-ADRDA and DSM-III-R criteria, SPECT, X-ray CT, and APO E4 medial temporal lobe dementias. The Oxford Project to Investigate Memory and Aging.
    Jobst KA; Barnetson LP; Shepstone BJ
    Int Psychogeriatr; 1997; 9 Suppl 1():191-222; discussion 247-52. PubMed ID: 9447442
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acetazolamide-challenged perfusion magnetic resonance imaging for assessment of cerebrovascular reserve capacity in patients with symptomatic middle cerebral artery stenosis: comparison with technetium-99m-hexamethylpropyleneamine oxime single-photon emission computed tomography.
    Kim HJ; Kim TW; Ryu SY; Yang PS; Kwon MJ; Kim JC; Lee YS; Lee HJ; Yang JH; Kim JK; Chung YA; Oh EY; Lee SB
    Clin Imaging; 2011; 35(6):413-20. PubMed ID: 22040783
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CSF biomarkers, impairment of cerebral hemodynamics and degree of cognitive decline in Alzheimer's and mixed dementia.
    Stefani A; Sancesario G; Pierantozzi M; Leone G; Galati S; Hainsworth AH; Diomedi M
    J Neurol Sci; 2009 Aug; 283(1-2):109-15. PubMed ID: 19278690
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Perfusion computed tomography evaluation of cerebral hemodynamic impairment in patients with unilateral chronic steno-occlusive disease: a comparison with the acetazolamide challenge 99mTc-hexamethylpropyleneamine oxime single-photon emission computed tomography.
    Kim E; Sohn CH; Na DG; Kim JE; Chang KH; Kim JH; Jeon SJ
    J Comput Assist Tomogr; 2009; 33(4):546-51. PubMed ID: 19638847
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuropsychological, psychiatric, and cerebral blood flow findings in vascular dementia and Alzheimer's disease.
    Starkstein SE; Sabe L; Vazquez S; Teson A; Petracca G; Chemerinski E; Di Lorenzo G; Leiguarda R
    Stroke; 1996 Mar; 27(3):408-14. PubMed ID: 8610304
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cerebrovascular resistance: effects on cognitive decline, cortical atrophy, and progression to dementia.
    Yew B; Nation DA;
    Brain; 2017 Jul; 140(7):1987-2001. PubMed ID: 28575149
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.